Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rheumatoid Arthritis
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01881308
- Collaborators
- The Research Council of Norway
- South-Eastern Norway Regional Health Authority
- Investigators
- Principal Investigator: Espen A. Haavardsholm, MD PhD Diakonhjemmet Hospital Study Director: Tore K Kvien, MD PhD Diakonhjemmet Hospital